{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:27Z","timestamp":1793110947517,"version":"4.5.0"},"reference-count":24,"publisher":"Massachusetts Medical Society","issue":"19","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"name":"RemeGen"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2026,5,14]]},"DOI":"10.1056\/nejmoa2514415","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:00:43Z","timestamp":1778706043000},"page":"1916-1924","source":"Crossref","is-referenced-by-count":25,"title":["Telitacicept for IgA Nephropathy \u2014 Interim Analysis of a Phase 3 Trial"],"prefix":"10.1056","volume":"394","author":[{"given":"Jicheng","family":"Lv","sequence":"first","affiliation":[{"name":"Renal Division, Peking University First Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liu","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"RemeGen, Yantai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[{"name":"RemeGen, Yantai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zuraw","sequence":"additional","affiliation":[{"name":"Vor Biopharma, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[{"name":"University of New South Wales, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Fang","sequence":"additional","affiliation":[{"name":"RemeGen, Yantai, China"},{"name":"School of Life Science and Technology, Tongji University, Shanghai"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae252"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2023.12.016"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000135"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74475"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5535"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14045"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2017"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003099"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.5301\/jn.5000218"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01591-1"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.12.014"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.01.003"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01554-4"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02302-4"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409415"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410316"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2512133"},{"key":"e_1_3_5_22_2","article-title":"Results from longer follow-up with povetacicept, an enhanced dual BAFF\/APRIL antagonist, in IgA nephropathy (RUBY-3 study): FR-PO854.","volume":"35","author":"Madan A","year":"2024","unstructured":"Madan A, Yalavarthy R, Kim DK, et al. Results from longer follow-up with povetacicept, an enhanced dual BAFF\/APRIL antagonist, in IgA nephropathy (RUBY-3 study): FR-PO854. J Am Soc Nephrol 2024;35:10S. abstract.","journal-title":"J Am Soc Nephrol"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2510198"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.5368"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.01.024"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2514415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:00:44Z","timestamp":1778706044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2514415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":24,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,5,14]]}},"alternative-id":["10.1056\/NEJMoa2514415"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2514415","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}